Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Karayama

Showing results (171-180 of 194) with videos related to

Pageof 20
Sort By:
Respirology Case Reports|July 18, 2025
Alveolar Sarcoidosis Mimicking Idiopathic Interstitial Pneumonia Without Mediastinal LymphadenopathyHiroki Kanasaki, Noriyuki Enomoto, Yuko Tanaka, et al.
Cancer Science|July 9, 2020
Propensity score analysis of overall survival between first- and second-generation EGFR-TKIs using real-world dataKentaro Ito, Kenta Murotani, Akihito Kubo, et al.
Respiration; International Review of Thoracic Diseases|January 5, 2021
Pneumothorax in Patients with Idiopathic Pleuroparenchymal Fibroelastosis: Incidence, Clinical Features, and Risk FactorsMasato Kono, Yutaro Nakamura, Yasunori Enomoto, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 26, 2017
Persistent impairment on spirometry in chronic eosinophilic pneumonia: A longitudinal observation study (Shizuoka-CEP study)Yuzo Suzuki, Yoshiyuki Oyama, Hironao Hozumi, et al.
Journal for Immunotherapy of Cancer|July 27, 2023
Six-week oral prednisolone therapy for immune-related pneumonitis: a single-arm phase II studyMasato Karayama, Naoki Inui, Yusuke Inoue, et al.
Respiratory Medicine|November 28, 2017
Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: A retrospective multicenter studyYasunori Enomoto, Yutaro Nakamura, Yasuomi Satake, et al.
NPJ Precision Oncology|March 14, 2025
Lethal co-expression intolerance underlies the mutually exclusive expression of ASCL1 and NEUROD1 in SCLC cellsHirofumi Watanabe, Yusuke Inoue, Kazuo Tsuchiya, et al.
BMC Pulmonary Medicine|October 8, 2024
Risk factors for relapse of immune-related pneumonitis after 6-week oral prednisolone therapy: a follow-up analysis of a phase II studyMasato Karayama, Naoki Inui, Yusuke Inoue, et al.
Journal of Clinical Medicine|April 30, 2021
Prognostic and Clinical Value of Cluster Analysis in Idiopathic Pleuroparenchymal Fibroelastosis PhenotypesYutaro Nakamura, Kazutaka Mori, Yasunori Enomoto, et al.
JTO Clinical and Research Reports|July 4, 2025
Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort StudiesYusuke Inoue, Yoshihiro Kitahara, Masato Karayama, et al.
Pageof 20

Showing results (171-180 of 194) with videos related to

Sort By:
Pageof 20
Respirology Case Reports|July 18, 2025
Alveolar Sarcoidosis Mimicking Idiopathic Interstitial Pneumonia Without Mediastinal LymphadenopathyHiroki Kanasaki, Noriyuki Enomoto, Yuko Tanaka, et al.
Cancer Science|July 9, 2020
Propensity score analysis of overall survival between first- and second-generation EGFR-TKIs using real-world dataKentaro Ito, Kenta Murotani, Akihito Kubo, et al.
Respiration; International Review of Thoracic Diseases|January 5, 2021
Pneumothorax in Patients with Idiopathic Pleuroparenchymal Fibroelastosis: Incidence, Clinical Features, and Risk FactorsMasato Kono, Yutaro Nakamura, Yasunori Enomoto, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 26, 2017
Persistent impairment on spirometry in chronic eosinophilic pneumonia: A longitudinal observation study (Shizuoka-CEP study)Yuzo Suzuki, Yoshiyuki Oyama, Hironao Hozumi, et al.
Journal for Immunotherapy of Cancer|July 27, 2023
Six-week oral prednisolone therapy for immune-related pneumonitis: a single-arm phase II studyMasato Karayama, Naoki Inui, Yusuke Inoue, et al.
Respiratory Medicine|November 28, 2017
Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: A retrospective multicenter studyYasunori Enomoto, Yutaro Nakamura, Yasuomi Satake, et al.
NPJ Precision Oncology|March 14, 2025
Lethal co-expression intolerance underlies the mutually exclusive expression of ASCL1 and NEUROD1 in SCLC cellsHirofumi Watanabe, Yusuke Inoue, Kazuo Tsuchiya, et al.
BMC Pulmonary Medicine|October 8, 2024
Risk factors for relapse of immune-related pneumonitis after 6-week oral prednisolone therapy: a follow-up analysis of a phase II studyMasato Karayama, Naoki Inui, Yusuke Inoue, et al.
Journal of Clinical Medicine|April 30, 2021
Prognostic and Clinical Value of Cluster Analysis in Idiopathic Pleuroparenchymal Fibroelastosis PhenotypesYutaro Nakamura, Kazutaka Mori, Yasunori Enomoto, et al.
JTO Clinical and Research Reports|July 4, 2025
Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort StudiesYusuke Inoue, Yoshihiro Kitahara, Masato Karayama, et al.
Pageof 20